Home › Type 2 Diabetes › Louisiana › Monroe
Type 2 Diabetes clinical trials in Monroe, LA
5 studies for Type 2 Diabetes are looking for participants at sites in and around Monroe (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- IMA Clinical Research Monroe, Monroe
- Monroe Research, LLC, West Monroe · 2 mi away
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- IMA Clinical Research Monroe-Main, Monroe
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
RecruitingPhase 3
- Research Site, Monroe
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
- IMA Clinical Research, Monroe
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RecruitingPhase 3
- Ima Clinical Research- Monroe, Monroe
About Type 2 Diabetes
Type 2 Diabetes, previously referred to as Adult Onset Diabetes, is the more common type. Risk factors include obesity and family history.
More about Type 2 Diabetes on MedlinePlus
Type 2 Diabetes trials in other cities
- San Antonio, TX37 studies
- Houston, TX31 studies
- Orlando, FL25 studies
- Atlanta, GA21 studies
- San Diego, CA21 studies
- Boston, MA20 studies
- Miami, FL20 studies
- Chicago, IL19 studies
- Arlington, VA19 studies
- Los Angeles, CA18 studies
- Dallas, TX18 studies
- Columbus, OH17 studies
Other studies in Monroe
- Obesity5 studies
- Overweight5 studies
- Steatotic Liver Disease5 studies
- Heart Failure4 studies
- Atrial Fibrillation4 studies
- High Blood Pressure4 studies
- Crohn's Disease3 studies
- Cardiovascular Disease3 studies
- Blood Clots3 studies
- Liver Diseases3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.